Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The estrogen--cancer controversy.

R B Greenblatt, L D Stoddard

    Journal of the American Geriatrics Society
    |January 1, 1978
    PubMed
    Summary

    Postmenopausal women can safely use estrogen therapy. A review found no confirmed link between estrogen use and endometrial cancer, suggesting benefits outweigh risks.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Menopausal arthritis.

    The Medical clinics of North America·2010
    Same author

    Treatment of granuloma inguinale with diramin; a new antimonial.

    The Journal of venereal disease information·2010
    Same author

    The two-hour pregnancy test.

    Southern medical journal·2010
    Same author

    The relationship between the steroid hormones and experimentally-induced tumors in rats.

    The Anatomical record·2010
    Same author

    Studies on the variations of blood gonadotropins and vaginal smears during pregnancy in correlation with the fetal sex.

    The Journal of clinical endocrinology and metabolism·2010
    Same author

    Some endocrinologic aspects of retarded growth and dwarfism.

    The Medical clinics of North America·2010

    Area of Science:

    • Gynecology
    • Oncology
    • Endocrinology

    Background:

    • The use of estrogen therapy in postmenopausal women is controversial due to concerns about endometrial cancer.
    • Recent studies have questioned the alleged causal relationship between estrogens and endometrial cancer.

    Purpose of the Study:

    • To re-evaluate the association between estrogen therapy and endometrial cancer in postmenopausal women.
    • To determine if the benefits of hormone replacement therapy outweigh the potential risks.

    Main Methods:

    • A review of three key publications claiming an estrogen-endometrial cancer link was conducted by biostatisticians.
    • Analysis of endometrial cancer incidence trends in relation to estrogen use patterns.
    • Histopathological evaluation of endometrial tissue and response to progestogen challenge.

    Main Results:

    • Biostatistical review found no confirmed association between estrogen therapy and endometrial cancer.
    • Endometrial cancer incidence has increased globally, independent of widespread estrogen use.
    • Histologic overdiagnosis of endometrial cancer and the potential for progestogen therapy to differentiate pseudomalignancy were noted.

    Conclusions:

    • The alleged causal relationship between estrogens and endometrial cancer is not confirmed by expert review.
    • Hormone replacement therapy benefits for postmenopausal women significantly outweigh the putative risks of endometrial cancer.
    • Progestogen administration can mitigate risks associated with unopposed estrogen therapy.

    Related Experiment Videos